Subscribe

Psychosocial Support Reducing the Cost of Cancer

Video
Videos
According to Vicki Kennedy, early research indicates that psychosocial support can provide cost-savings by reducing hospital readmissions, decreased emergency department visits, and better utilization of staff. There are many groups doing research to determine the cost-effectiveness of these new patient standards.

Related Items

Educating Patients About the Need to Wait for Biomarker Test Results
By Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T); Cathy Simmons, RN, BSN, ONN-CG(T); Lauren Welch, MSN, NP-C, AOCNP
Videos
Interview with the Innovators, Video
Explaining the Treatment Trajectory in NSCLC
By Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T); Cathy Simmons, RN, BSN, ONN-CG(T); Lauren Welch, MSN, NP-C, AOCNP
Videos
Interview with the Innovators, Video
Reflecting on Advances in NSCLC Treatment Over the Past 10 Years
By Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T); Cathy Simmons, RN, BSN, ONN-CG(T); Lauren Welch, MSN, NP-C, AOCNP
Videos
Interview with the Innovators, Video
Counseling Patients and Their Families on Treatment Options in NSCLC
By Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T); Cathy Simmons, RN, BSN, ONN-CG(T); Lauren Welch, MSN, NP-C, AOCNP
Videos
Interview with the Innovators, Video
The Role of NGS Testing in NSCLC
By Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T); Cathy Simmons, RN, BSN, ONN-CG(T); Lauren Welch, MSN, NP-C, AOCNP
Videos
Interview with the Innovators, Video
An Expert Perspective on the Current and Future of Maintenance Therapy in Ovarian Cancer
By Amina Ahmed, MD; Paula Anastasia, RN, MN, AOCN; Ali McBride, PharmD, MS, BCPS
Videos
Interview with the Innovators, Video
Immunotherapy in Combination with PARP Inhibitors as First-Line Maintenance Therapy in Ovarian Cancer
By Amina Ahmed, MD; Paula Anastasia, RN, MN, AOCN; Ali McBride, PharmD, MS, BCPS
Videos
Interview with the Innovators, Video
Adverse Events and Improvements in Quality of Life Associated with First-Line Maintenance Therapy in Ovarian Cancer
By Paula Anastasia, RN, MN, AOCN; Ali McBride, PharmD, MS, BCPS
Videos
Interview with the Innovators, Video
Management of Adverse Events Associated with PARP Inhibitors as First-Line Maintenance Therapy in Ovarian Cancer
By Ali McBride, PharmD, MS, BCPS; Paula Anastasia, RN, MN, AOCN
Videos
Interview with the Innovators, Video
Combination Therapy as Maintenance in Ovarian Cancer
By Amina Ahmed, MD; Ali McBride, PharmD, MS, BCPS; Paula Anastasia, RN, MN, AOCN
Videos
Interview with the Innovators, Video

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, monthly TON print publication and TON weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.